Lack of expression of long-term potentiation in the dentate gyrus but not in the CA1 region of the hippocampus of μ-opioid receptor-deficient mice

Neuropharmacology

Volumn 39, Issue 6, 2000, Pages 952-960

  Matthies, Henry ^a   Schroeder, Helmut ^a   Becker, Axel ^a   Loh, Horace ^b   Höllt, Volker ^a   Krug, Manfred ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

opioid receptor; opioid deficient mutant mice; Binding assay; Funaltrexamine; Hippocampus; Long term potentiation; Synaptic plasticity

Indexed keywords

FUNALTREXAMINE; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DENTATE GYRUS; DOPAMINERGIC SYSTEM; GABAERGIC SYSTEM; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR BINDING; RECEPTOR UPREGULATION;

ACTION POTENTIALS; ANIMALS; CORPUS STRIATUM; DENTATE GYRUS; FEMALE; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; MICE; MICE, MUTANT STRAINS; NALTREXONE; NARCOTIC ANTAGONISTS; RECEPTORS, DOPAMINE D1; RECEPTORS, DOPAMINE D2; RECEPTORS, GLUTAMATE; RECEPTORS, OPIOID, MU; SYNAPTIC MEMBRANES;

EID: 0034015401     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(99)00203-8     Document Type: Article

References (36)

1. Arvidson U., Riedl M., Chakrabarti S., Lee J.-H., Nakano A.H., Dado R.J., Loh H.H., Law P.-Y., Wessendorf M.W., Elde R. Distribution and targeting of a μ-opioid receptor (MOR1) in brain and spinal cord. Journal of Neuroscience. 15:1995;3328-3341.
2. Bausch S.B., Patterson T.A., Ehrengruber M.U., Lester H.A., Davidson N., Chavkin C. Colocalization of mu opioid receptors with GIRK1 potassium channels in the rat brain: an immunocytochemical study. Receptors and Channels. 3:1995;221-241.
3. Bliss T.V.P., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 361:1993;31-39.
4. Blitzer R.D., Gil O., Landau E.M. Cholinergic stimulation enhanced long-term potentiation in the CA1 region of rat hippocampus. Neuroscience Letters. 119:1990;207-210.
5. Bramham C.R. Opioid receptor dependent long-term potentiation: Peptidergic regulation of synaptic plasticity in the hippocampus. Neurochemistry International. 20:1992;441-455.
6. Bramham C.R., Sarvey J.M. Endogenous activation of mu and delta-1 opioid receptors is required for long-term potentiation induction in the lateral perforant path: dependence on GABAergic inhibition. Journal of Neuroscience. 16:1996;8123-8131.
7. Bramham C.R., Errington M.L., Bliss T.V.P. Naloxone blocks the induction of long-term potentiation in the lateral but not in the medial perforant pathway in the anesthetized rat. Brain Research. 449:1988;352-356.
8. Commons K.G., Milner T.A. Ultrastructural heterogentity of enkephalin-containing terminals in the rat hippocampal formation. Journal of Comparative Neurology. 358:1995;324-342.
9. Commons K.G., Milner T.A. Cellular and subcellular localization of d opioid receptor immunoreactivity in the rat dentate gyrus. Brain Research. 738:1996;181-195.
10. Dahl D., Sarvey J.M. β-adrenergic agonist-induced long-lasting synaptic modificatios in hippocampal dentate gyrus require activation of NMDA receptors, but not electrical activation of afferents. Brain Research. 526:1990;347-350.
11. Ding Y.-Q., Kaneko T., Nomura S., Mizuno N. Immunohistochemical localization of μ-opioid receptors in the central nervous system of the rat. Journal of Comparative Neurology. 367:1996;375-402.
12. Frey U., Hartmann S., Matthies H. Domperidone, an inhibitor of the D2-receptor, blocks a late phase of an electrically induced long-term potentiation in the CA1-region in rats. Biomedica Biochemica Acta. 48:1989;473-476.
13. Frey U., Matthies H., Reymann K.G., Matthies H. The effect of dopaminergic D1 receptor blockade during tetanization on the expression of long-term potentiation in the rat CA1 region in vitro. Neuroscience Letters. 129:1991;111-114.
14. Hanse E., Gustafson B. Long-term potentiation and field EPSPs in the lateral and medial perforant paths in the dentate gyrus in vitro: A comparison. European Journal of Neuroscience. 4:1992;1191-1201.
15. Hinds H.L., Tonegawa S., Malinow R. CA1 long-term potentiation is diminished but present in hippocampal slices from α-CaMKII mutant mice. Learning and Memory. 5:1998;344-354.
16. Jia Z., Lu Y.-M., Henderson J., Taverna F., Romano C., Abramow-Newerly W., Wojtowicz J.M., Roder J. Selective abolition of the NMDA component of long-term potentiation in mice lacking mGluR5. Learning and Memory. 5:1998;331-343.
17. Kieffer B.L. Opioids: first lessions from knockout mice. Trends in Pharmacological Sciences. 20:1999;19-26.
18. Kitchen J., Slowe S.J., Matthes H.W.D., Kieffer B. Quantitative autoradiographic mapping of m-, d - and kappa-opioid receptors in knockout mice lacking the m-opioid receptor gene. Brain Research. 778:1997;73-88.
19. Köhler U., Schroeder H., Augustin W., Sabel B.A. A new animal model of dopamine supersensitivity using subcutaneous implantation of haloperidol releasing polymers. Neuroscience Letters. 170:1994;99-102.
20. Lambert N.A., Harrison N.L., Teyler T.J. Evidence for μ opiate receptors on inhibitory terminals in area CA1 of rat hippocampus. Neuroscience Letters. 124:1991;101-104.
21. Linseman M.A., Corrigall W.A. Are endogenous opiates involved in potentation of field potentials in hippocampus of the rat. Neuroscience Letters. 27:1981;319-324.
22. Loh H.H., Liu H.C., Cavalli A., Yang W., Chen Y.F., Wei L.N. Mu opioid receptor knockout in mice: effects on ligand-induced analgesia and morphine lethality. Molecular Brain Research. 54:1998;321-326.
23. Mansour A., Fox C.A., Burke S., Meng F., Thompson R.C., Akil H., Watson S.J. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. Journal of Comparative Neurology. 350:1994;438.
24. Matthes H.W.D., Smadja C., Valverde O., Vonesch J.-L., Foutz A.S., Boudinot E., Denavit-Saubie M., Severini C., Negri L., Roques B.P., Maldonado R., Kieffer B.L. Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor. Journal of Neuroscience. 18:1998;7285-7295.
25. Matthies H. In search of cellular mechanisms of memory. Progress in Neurobiology. 32:1989;277-349.
26. Matthies H., Becker A., Schroeder H., Kraus J., Höllt V., Krug M. Dopamine D1-deficient mutant mice do not express the late phase of hippocampal long-term potentiation. Neuroreport. 8:1997;3533-3535.
27. Moskowitz A.S., Goodman R.R. Autoradiographic distribution of Mu1 and Mu2 opioid binding in the mouse central nervous system. Brain Research. 360:1985;117-129.
28. Neumaier J.F., Mailheau S., Chavkin C. Opioid receptor-mediated responses in the gyrus dentatus and CA1 region of the rat hippocampus. The Journal of Pharmacology and Experimental Therapeutics. 244:1988;564-570.
29. Nosten-Bertrand M., Errington M.L., Murphy K.P.S.J., Tokugawa Y., Barboni E., Kozlova E., Michalovich D., Morris R.G.M., Silver J., Stewart C.L., Bliss T.V.P., Morris R.J. Normal spatial learning despite regional inhibition of LTP in mice lacking Thy-1. Nature. 379:1996;826-829.
30. Piguet P., North R.A. Opioid actions at mu and delta receptors in the rat dentate gyrus in vitro. The Journal of Pharmacology and Experimental Therapeutics. 266:1993;1139-1146.
31. Schroeder H., Becker A., Lössner B. Glutamate binding to brain membrane is increased in Pentylenetetrazol-kindled rats. Journal of Neurochemistry. 60:1993;1007-1011.
32. Schurmans St., Schiffmann S.N., Gurden H., Lemaire M., Lipp H.-P., Schwam V., Pochet R., Imperato A., Böhme G.A., Parmentier M. Impaired long-term potentiation induction in gyrus dentatus of calretinin-deficient mice. Proceedings of the National Academy of Sciences. 94:1997;10415-10420.
33. Simmons M.L., Chavkin Ch. Endogenous opioid regulation of hippocampal function. International Review of Neurobiology. 39:1996;145-196.
34. Stringer J.L., Greenfield L.J., Hackett J.T., Guyenet P.G. Blockade of long-term potentiation by Phencyclidine and σ opiates in the hippocampus in vivo and in vitro. Brain Research. 280:1983;127-138.
35. Xie C.W., Lewis D.V. Opioid-mediated facilitation of long-term potentiation at the lateral perforant path-dentate granule cell synapse. The Journal of Pharmacology and Experimental Therapeutics. 256:1991;289-296.
36. Zieglgänsberger W., French E.D., Siggins G.R., Bloom F.E. Opioid peptids may excite hippocampal pyramidal neurons by inhibiting adjacent inhibitory interneurons. Science. 205:1979;415-417.